LBRX

LB Pharmaceuticals Inc

Company Overview

This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.

SectorHealthcare

IndustryBiotechnology

Market Cap$1.4B

Employees49

CEOHeather D. Turner

Websitehttps://lbpharma.us

Valuation

Current Price$49.34

Fair Value?$000.00

Valuation?No valuation

Hist. PE ?N/Aⓘ

EPS (TTM) ?-2.84

Forward EPS Growth ?—

Historical Growth ?122.19%

Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price

EPS

Revenue

Equity

Pro

Available on the Pro plan

Free Cash Flow

Pro

Available on the Pro plan

Long Term Debt

Pro

Available on the Pro plan

Net Profit

Pro

Available on the Pro plan

Shares Outstanding

Pro

Available on the Pro plan

Last updated: 9/5/2026, 6:29:09 PM